Prio Wealth Limited Partnership Novo Nordisk A S Transaction History

Prio Wealth Limited Partnership

  • $3.38 Billion
  • Q3 2024

A detailed history of Prio Wealth Limited Partnership transactions in Novo Nordisk A S stock. As of the latest transaction made, Prio Wealth Limited Partnership holds 199,113 shares of NVO stock, worth $21.4 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares
199,113
Previous 201,898 1.38%
Holding current value
$21.4 Million
Previous $28.8 Million 17.73%
% of portfolio
0.7%
Previous 0.87%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024
SELL
$119.07 - $145.42 $331,609 - $404,994
-2,785 Reduced 1.38%
199,113 $23.7 Million
Q2 2024

Sep 10, 2024
BUY
$122.71 - $146.91 $758,470 - $908,050
6,181 Added 3.16%
201,898 $28.8 Million
Q1 2024

May 14, 2024
BUY
$102.11 - $135.92 $9.91 Million - $13.2 Million
97,069 Added 98.4%
195,717 $25.1 Million
Q4 2023

Jan 22, 2024
BUY
$87.78 - $105.45 $5.34 Million - $6.41 Million
60,832 Added 160.86%
98,648 $10.2 Million
Q3 2023

Oct 31, 2023
BUY
$90.94 - $199.54 $1.68 Million - $3.68 Million
18,458 Added 95.35%
37,816 $3.44 Million
Q1 2023

May 12, 2023
SELL
$132.34 - $159.14 $9,263 - $11,139
-70 Reduced 0.36%
19,358 $3.08 Million
Q4 2022

Feb 13, 2023
SELL
$102.55 - $135.33 $29,329 - $38,704
-286 Reduced 1.45%
19,428 $0
Q2 2022

Feb 27, 2023
BUY
$103.24 - $121.81 $32,830 - $38,735
318 Added 1.64%
19,746 $2.2 Million
Q1 2022

Feb 21, 2023
BUY
$93.1 - $112.54 $29,605 - $35,787
318 Added 1.64%
19,746 $2.19 Million
Q4 2021

Feb 17, 2022
SELL
$95.88 - $117.08 $28,859 - $35,241
-301 Reduced 1.5%
19,714 $2.21 Million
Q2 2021

Aug 16, 2021
SELL
$67.66 - $84.76 $445,879 - $558,568
-6,590 Reduced 24.77%
20,015 $1.68 Million
Q1 2021

May 06, 2021
SELL
$67.06 - $75.82 $1.17 Million - $1.33 Million
-17,520 Reduced 39.71%
26,605 $1.79 Million
Q1 2020

May 13, 2020
SELL
$49.46 - $64.78 $11,128 - $14,575
-225 Reduced 0.51%
44,125 $2.66 Million
Q3 2019

Nov 13, 2019
SELL
$47.54 - $53.43 $142,620 - $160,290
-3,000 Reduced 6.34%
44,350 $2.29 Million
Q4 2018

Feb 06, 2019
SELL
$41.54 - $47.25 $62,310 - $70,875
-1,500 Reduced 3.07%
47,350 $2.18 Million
Q1 2018

Apr 17, 2018
BUY
$48.49 - $58.14 $2.37 Million - $2.84 Million
48,850 New
48,850 $2.41 Million

Others Institutions Holding NVO

# of Institutions
1,951
Shares Held
320M
Call Options Held
5.22M
Put Options Held
5M
View Full List

About NOVO NORDISK A S

NVO Quotes by TradingView
  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $243B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Prio Wealth Limited Partnership Portfolio

Follow Prio Wealth Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prio Wealth Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Prio Wealth Limited Partnership with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email